Company snapshot
Market Cap
$22B
Large-cap2016 — today
10-Year Price
+1066%
2016 — today
52-Week Range
$161.37$280.77
Current $264.51· 86%
Featured in rankings
Most Undervalued Healthcare StocksBest Healthcare GARP StocksMost Undervalued Value StocksMost Undervalued Growth StocksBest GARP Stocks (Growth at a Reasonable Price)Cheapest Large-Cap Stocks
Rankings recomputed after each US market close — see where THC stands against peers.
Similar companies
| Company | P/E | Div yield |
|---|---|---|
| ZTSZoetis Inc. | 12.1 | 2.8% |
| ALCAlcon Inc. | 52.1 | 0.5% |
| CNCCentene Corporation | -6.6 | — |
| ALNYAlnylam Pharmaceuticals, Inc. | 42.2 | — |
| ONCBeOne Medicines Ltd. | 4.9 | — |
| IDXXIDEXX Laboratories, Inc. | 36.1 | — |
| AAgilent Technologies, Inc. | 28.9 | 0.5% |
| RVMDRevolution Medicines, Inc. | -23.2 | — |
Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.
Valuation in context
P/E ratio
10.2
Above average
Pricier than usual over the last 10 years
Sector median 25.2below sector
P/B ratio
2.6
Near historic high
Near historic highs — last 10 years
Sector median 2.5in line with sector
EV / EBITDA
6.6
Below average
Below the 10-year average
Sector median 15.4below sector
PEG ratio
0.2
Below average
Below the 10-year average
Sector median 1.5below sector
FCF Yield
13.6%
Around average
Around the 10-year average
Sector median -10.1%above sector